Pharmacological treatments for alcoholism: Revisiting lithium and considering buspirone

Alcoholism: Clinical and Experimental Research

Volumn 24, Issue 5, 2000, Pages 666-674

  Fawcett, Jan ^a,b   Kravitz, Howard M ^a,b,d   McGuire, Marcella ^a   Easton, Michael ^a,b   Ross, Jeffrey ^a,b   Pisani, Vincent ^a,b   Fogg, Louis F ^a,b   Clark, David ^a,b   Whitney, Michael ^a   Kravitz, Glenda ^a   Javaid, Javaid ^a   Teas, Gregory ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c ALEXIAN BROTHERS MEDICAL CENTER   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alcoholism; Buspirone; Depression; Lithium; Psychopharmacotherapy

Indexed keywords

BUSPIRONE; LITHIUM; PLACEBO;

ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESEARCH; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TREATMENT PLANNING;

EID: 0034043757     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2000.tb02038.x     Document Type: Article

References (59)

1. Agresti A, Finlay B (1986) Statistical Methods for the Social Sciences. 2nd ed. Dellen Publishing, San Francisco.
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. American Psychiatric Association, Washington, DC.
3. Anton RF (1996) Neurobehavioral basis for the pharmacotherapy of alcoholism: Current and future directions. Alcohol Alcohol (Suppl. 1) 1:43-53.
4. Anton RF, Moak DH, Waid R, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of out-patient alcoholics: Results of a placebo-controlled trial. Am J Psychiatry 156:1758-1764.
5. Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 56:893-897.
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
7. Bolotova ZN, Polotnikov AG, Barv AM (1977) Lithium treatment in alcoholic patients. Zh Nevropatol Psikhiatr 77:1235-1237.
8. Bruno F (1989) Buspirone in the treatment of alcoholic patients. Psychopathology (Suppl. 1) 22:49-59.
9. Clark DC, Fawcett J (1989) Does lithium carbonate therapy for alcoholism deter relapse drinking? Recent Dev Alcohol 7:315-328.
10. Diaz-Marot A, Puigdellivol E, Salvatella C, Comellas L, Gassiot M (1989) Determination of buspirone and 1-(2-pyrimidinyl)piperazine in plasma by high-performance liquid chromatography. J Chromatogr 490:470-473.
11. Dorus W, Ostrow DG, Anton R, Cushman P, Collins JF, Schaefer M, Charles HL, Desai P, Hayashida M, Malkerneker U, Willenbring M, Fiscella R, Sather MR (1989) Lithium treatment of depressed and nondepressed alcoholics. JAMA 262:1646-1652.
12. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766-771.
13. Fawcett J, Clark DC, Aagesen CA, Pisani VD, Tilkin JM, Sellers D, McGuire M, Gibbons RD (1987) A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. Arch Gen Psychiatry 44:248-256.
14. Fawcett J, Clark DC, Gibbons RD, Aagesen CA, Pisani VD, Tilkin JM, Sellers D, Stutzman D (1984) Evaluation of lithium therapy for alcoholism. J Clin Psychiatry 45:495-499.
15. Florenzano R, Feuerhake O, Retamal P, Venegas F, Yazigi C, Palma MI (1982) Ensayo terapeutico de carbonato de litio en pacientes alcoholicos ambulatorios. Rev Med Chile 110:1071-1074.
16. Fuller RK (1991) Assessment of treatment outcome. Alcohol Alcohol Suppl 1:519-522.
17. Fuller RK, Lee KK, Gordis E (1988) Validity of self-report in alcoholism research: Results of a Veterans Administration cooperative study. Alcohol Clin Exp Res 12:201-205.
18. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT (1999) Pharmacological treatment of alcohol dependence: A review of the evidence. JAMA 281:1318-1325.
19. George DT, Rawlings R, Eckardt MJ, Phillips MJ, Shoaf SE, Linnoila M (1999) Buspirone treatment of alcoholism: Age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking. Alcohol Clin Exp Res 23:272-278.
20. Goldman HH, Skodol AE, Lave TR (1992) Revising Axis V for DSM-IV: A review of measures of social functioning. Am J Psychiatry 149:1148-1156.
21. Gordis E, Fuller RK, Hewitt BG (1989) Alcoholism treatment research: New directions for an old problem. JAMA 262:1680-1681.
22. Gorelick DA (1993) Pharmacological treatment. Recent Dev Alcohol 11:413-427.
23. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, Michael J (1998) The effect of depression on return to drinking: A prospective study. Arch Gen Psychiatry 55:259-265.
24. Greenberg RP, Fisher S (1989) Examining antidepressant effectiveness: Findings, ambiguities and some vexing puzzles, in The Limits of Biological Treatments for Psychological Distress: Comparisons with Psychotherapy and Placebo (Fisher S, Greenberg RP eds), pp 1-38. Erlbaum and Associates, Hillsdale, NJ.
25. Hasin DS, Nunes EV (1998) Comorbidity of alcohol, drug, and psychiatric disorders: Epidemiology, in Dual Diagnosis and Treatment. Substance Abuse and Comorbid Medical and Psychiatric Disorders (Kranzler HR, Rounsaville BJ eds), pp 1-30. Marcel Dekker, New York.
26. Hedeker D, Gibbons RD (1996) MIXREG: A computer program for mixed-effects regression analysis with autocorrelated errors. Comput Methods Programs Biomed 49:229-252.
27. Hedeker D, Gibbons RD (1997) Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychol Methods 2:64-78.
28. Jones SH, Thornicroft G, Coffey M, Dunn G (1995) A brief mental health outcome scale: Reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry 166:654-659.
29. Kline NS, Wren JC, Cooper TB, Varga E, Canal O (1974) Evaluation of lithium therapy in chronic and periodic alcoholism. Am J Med Sci 268:15-22.
30. Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner R, Brown J, Bohn MJ (1994) Buspirone treatment of anxious alcoholics: A placebo-controlled trial. Arch Gen Psychiatry 51:720-731.
31. Kranzler HR, Meyer RE (1989) An open trial of buspirone in alcoholics (letter). J Clin Psychopharmacol 9:379-380.
32. Leckliter N, Matarazzo JD (1989) The influence of age, education, IQ, gender, and alcohol abuse on Halstead-Reitan Neuropsychological Test Battery performance. J Clin Psychol 45:484-512.
33. Lee ET (1992) Statistical Methods for Survival Data Analysis. 2nd ed. John Wiley, New York.
34. Litten RZ, Allen JR (1993) Reducing the desire to drink: Pharmacology and neurobiology. Recent Dev Alcohol 11:325-344.
35. Malcolm R, Anton RF, Randall CL, Johnston A, Brady K, Thevos A (1992) A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 16:1007-1013.
36. Malec E, Malec T, Gagne MA, Dongier M (1996a) Buspirone in the treatment of alcohol dependence: A placebo-controlled trial. Alcohol Clin Exp Res 20:307-312.
37. Malec TS, Malec EA, Dongier M (1996b) Efficacy of buspirone in alcohol dependence: A review. Alcohol Clin Exp Res 20:853-858.
38. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB (1996) A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 275:761-767.
39. Merry J, Reynolds CM, Bailey J, Coppen A (1976) Prophylactic treatment of alcoholism by lithium carbonate: A controlled study. Lancet 2:481-482.
40. Moncrieff J, Drummond DC (1997) New drug treatments for alcohol problems: A critical appraisal. Addiction 92:939-947.
41. O'Malley SS, Croop RS, Wroblewski JM, Labriola DF, Volpicelli JR (1995) Naltrexone in the treatment of alcohol dependence: A combined analysis of two trials. Psychiatr Ann 25:681-688.
42. O'Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld R, Meyer RE, Rounsaville B (1996) Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 53:217-224.
43. Paulson MJ, Lin T-T (1970) Predicting WAIS IQ from Shipley-Hartford scores. J Clin Psychol (Suppl.) 26:453-461.
44. Project MATCH Research Group (1997) Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking out-comes. J Stud Alcohol 58:7-29.
45. Reitan RM (1958) Validity of the Trailmaking Test as an indicator of organic brain damage. Percept Mot Skills 8:271-276.
46. 1A partial agonists in depression: A composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol (Suppl.) 10:67S-76S.
47. Sass H, Soyka M, Mann K, Zielgansberger W (1996) Relapse prevention by acamprosate: Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 53:673-680.
48. Schaffer A, Naranjo CA (1998) Recommended drug treatment strategies for the alcoholic patient. Drugs 56:571-585.
49. Sellers EM, Naranjo CA, Forgie L, Lawrin M (1985) The effects of buspirone, trazodone, and zimelidine on voluntary ethanol consumption in laboratory animals. Report prepared by the Bristol Myers Company, Princeton, NJ.
50. Shipley WC (1940) A self-administering scale for measuring intellectual impairment and deterioration. J Psychol 9:371-377.
51. Smith A (1973, revised 1982) Symbol Digit Modalities Test. Western Psychological Services, Los Angeles.
52. Sobell MB, Maisto SA, Sobell LC, Cooper AM, Cooper TC, Sanders B (1980) Developing a prototype for evaluating alcohol treatment effectiveness, in Evaluating Alcohol and Drug Abuse Treatment Effectiveness, Recent Advances (Sobell LC, Sobell MB, Ward E eds), pp 129-150. Pergamon Press, New York.
53. Spitzer RL, Williams JBW, Gibbon M, First MB (1991) Structured Clinical Interview for DSM-III-R. Patient edition. American Psychiatric Association, Washington, DC.
54. Spitzer RL, Williams JBW, Gibbon M, First MB (1992) The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49:624-629.
55. Sussman N (1994) The uses of buspirone in psychiatry. J Clin Psychiatry Monogr 12:3-19.
56. Tollefson GD, Montague-Clouse J, Tollefson SL (1992) Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J Clin Psychopharmacol 12:19-26.
57. Wechsler D (1981) Manual for the Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation, San Antonio, TX.
58. Weissman MM, Bothwell S (1976) Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 33:1111-1115.
59. Weissman MM, Sholomskas D, John K (1981) The assessment of social adjustment: An update. Arch Gen Psychiatry 38:1250-1258.